GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD.

News Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Equities

002317

CNE100000HW4

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-09 EDT			5-day change	1st Jan Change
15.16 ^CNY	-1.94%		-0.07%	-5.55%

04-22	Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-11	Zhongsheng Pharma's Chairman to Raise Stake in Company	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
Zhongsheng Pharma's Chairman to Raise Stake in Company	03-11	MT
Zhongsheng Pharma's Unit Gets Nod to Market Mirabegron	01-18	MT
Zhongsheng Pharma Chairman Plans Boosting Stake	12-08	MT
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Zhongsheng Pharmaceutical Gets Drug Registration Certificate for Carbocysteine Oral Solution	23-10-18	MT
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-21	CI
Zhongsheng Pharmaceutical Gets Nod to Register Moxifloxacin Hydrochloride Eye Drops	23-07-31	MT
Zhongsheng Pharma Registers Mucolytic in China	23-07-06	MT
Zhongsheng Pharmaceutical Unit Completes Phase III Clinical Trial of Flu Drug	23-07-03	MT
Guangdong Zhongsheng Pharmaceutical Co., Ltd.(SZSE:002317) added to Shenzhen Stock Exchange Component Index	23-06-12	CI
Guangdong Zhongsheng Pharmaceutical Co., Ltd.(SZSE:002317) added to Shenzhen Stock Exchange Component A Share Index	23-06-12	CI
Zhongsheng Pharma Enrols Subjects in Phase IIb Clinical Trial of NASH Drug	23-06-05	MT
Zhongsheng Pharm Unit Enrolls First Subject for RAY1225 Injection Trial	23-05-22	MT
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 16 May 2023	23-05-10	CI
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2022	23-05-08	CI
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Announces Final Dividend Profit Distribution Proposal for 2022	23-04-11	CI
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-10	CI
Zhongsheng Pharma Gets Conditional Market Approval For Oral COVID-19 Drug	23-03-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Equities

002317

CNE100000HW4

Summary

Filters